Literature DB >> 20130980

Information from CTC measurements for metastatic breast cancer prognosis-we should do more than selecting an "optimal cut point".

T Fehm1, W Sauerbrei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20130980     DOI： 10.1007/s10549-010-0762-x

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  6 in total

Review 1.  [Chances and risks of blood-based molecular pathological analysis of circulating tumor cells (CTC) and cell-free DNA (cfDNA) in personalized cancer therapy: positional paper from the study group on liquid biopsy of the working group for molecular pathology in the German Society of Pathology (DGP)].

Authors:  E Dahl; A Jung; J Fassunke; M Hummel; R Penzel; W Dietmaier; S Laßmann
Journal:  Pathologe       Date:  2015-02       Impact factor: 1.011

2.  Detection of circulating tumor cells in patients with esophagogastric or pancreatic adenocarcinoma using the CellSearch® system: An observational feasibility study.

Authors:  Tobias Piegeler; Thomas Winder; Sabine Kern; Bernhard Pestalozzi; Paul Magnus Schneider; Beatrice Beck-Schimmer
Journal:  Oncol Lett       Date:  2016-06-30       Impact factor: 2.967

3.  Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies.

Authors:  Ulrike Weissenstein; Agnes Schumann; Marcus Reif; Susanne Link; Ulrike D Toffol-Schmidt; Peter Heusser
Journal:  BMC Cancer       Date:  2012-05-30       Impact factor: 4.430

4.  Untargeted Assessment of Tumor Fractions in Plasma for Monitoring and Prognostication from Metastatic Breast Cancer Patients Undergoing Systemic Treatment.

Authors:  Christoph Suppan; Iva Brcic; Verena Tiran; Hannah D Mueller; Florian Posch; Martina Auer; Erkan Ercan; Peter Ulz; Richard J Cote; Ram H Datar; Nadia Dandachi; Ellen Heitzer; Marija Balic
Journal:  Cancers (Basel)       Date:  2019-08-14       Impact factor: 6.639

5.  Evaluation of two different analytical methods for circulating tumor cell detection in peripheral blood of patients with primary breast cancer.

Authors:  B A S Jaeger; J Jueckstock; U Andergassen; J Salmen; F Schochter; V Fink; M Alunni-Fabbroni; M Rezai; Th Beck; M W Beckmann; K Friese; T W P Friedl; W Janni; B Rack
Journal:  Biomed Res Int       Date:  2014-04-08       Impact factor: 3.411

6.  Prognostic factors for patients with metastatic breast cancer: a literature review.

Authors:  Mengyu Hu; Bin Shao; Ran Ran; Huiping Li
Journal:  Transl Cancer Res       Date:  2021-04       Impact factor: 1.241
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.